lyphom inc said has tentat agre form joint ventur with privat held novopharm ltd canada wherebi each will market drug home countri lyphom will sell novopharm oral pharmaceut drug and novopharm will sell lyphom inject pharmaceut drug canada said joint ventur give lyphom entri into hospit and retail oral pharmaceut market with novopharm product line novopharm turn will strengthen it posit canadian hospit market use lyphom inject product first product market will cephalexin monohydr now market eli lilli keflex product whose patent expir april keflex antibiot with current market excess 250 mln dlrs will made novopharm canada sold new joint ventur and distribut lyphom said reuter 